Progress in the Field of GPIIb/IIIa Antagonists

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 2, 2004-04 ,pp. : 157-167

Bentham Science Publishers

Access to resources Recommend Favorite

Antithrombotic Effect of SM-20302, a Nonpeptide GPIIb/IIIa Antagonist, in a Photochemically Induced Thrombosis Model in Guinea Pigs - IMPACT-II

By Horisawa S.   Kaneko M.   Ikeda Y.   Ueki Y.   Sakurama T.  

Thrombosis Research, Vol. 94, Iss. 4, 1999-05 ,pp. : 227-234

Elsevier

Access to resources Recommend Favorite

Characterization of tumor-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells

By Oleksowicz L.   Mrowiec Z.   Schwartz E.   Khorshidi M.   Dutcher J.P.   Puszkin E.  

Thrombosis Research, Vol. 79, Iss. 3, 1995-08 ,pp. : 261-274

Elsevier

Access to resources Recommend Favorite

Synergistic Outside-In Regulation of Platelet Activation by GPIIb/IIIa Ligand-Induced Conformation and Oligomerization

By Wang X.-F.   Liu F.   Morris S.A.   Carroll R.C.  

Thrombosis Research, Vol. 104, Iss. 4, 2001-11 ,pp. : 239-247

Elsevier

Access to resources Recommend Favorite

Comparison of the Effect of Different Platelet GPIIb/IIIa Antagonists on the Dynamics of Platelet/Fibrin-Mediated Clot Strength Induced Using Thromboelastography

By Mousa S.A.   Forsythe M.S.  

Thrombosis Research, Vol. 104, Iss. 1, 2001-10 ,pp. : 49-56

Elsevier

Access to resources Recommend Favorite